Switch theme

🎉 M&A multiples are live!
Check it out!

Aelis Farma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Aelis Farma and similar public comparables like Julphar, Benevolent AI, and Galapagos.

All Drug Development & Therapeutics Multiples Start Free Trial
Aelis Farma logo Aelis Farma logo

Sign up to access all valuation multiples

Aelis Farma Overview

About Aelis Farma

Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Founded

2013

HQ

France
Employees

23

Website

aelisfarma.com

Financials

LTM Revenue $5.2M

Last FY EBITDA -$5.1M

EV

$10.1M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Aelis Farma Financials

Aelis Farma has a last 12-month revenue (LTM) of $5.2M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Aelis Farma achieved revenue of $10.2M and an EBITDA of -$5.1M.

Aelis Farma expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Aelis Farma valuation multiples based on analyst estimates

Aelis Farma P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $5.2M XXX $10.2M XXX XXX XXX
Gross Profit $5.2M XXX n/a XXX XXX XXX
Gross Margin 100% XXX n/a XXX XXX XXX
EBITDA n/a XXX -$5.1M XXX XXX XXX
EBITDA Margin n/a XXX -51% XXX XXX XXX
EBIT -$4.7M XXX -$7.3M XXX XXX XXX
EBIT Margin -91% XXX -71% XXX XXX XXX
Net Profit -$7.7M XXX -$5.7M XXX XXX XXX
Net Margin -148% XXX -56% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Aelis Farma Stock Performance

As of May 30, 2025, Aelis Farma's stock price is EUR 1 (or $1).

Aelis Farma has current market cap of EUR 16.5M (or $18.5M), and EV of EUR 9.0M (or $10.1M).

See Aelis Farma trading valuation data

Aelis Farma Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$10.1M $18.5M XXX XXX XXX XXX $-0.33

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Aelis Farma Valuation Multiples

As of May 30, 2025, Aelis Farma has market cap of $18.5M and EV of $10.1M.

Aelis Farma's trades at 1.0x EV/Revenue multiple, and -2.0x EV/EBITDA.

Equity research analysts estimate Aelis Farma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Aelis Farma has a P/E ratio of -2.4x.

See valuation multiples for Aelis Farma and 12K+ public comps

Aelis Farma Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $18.5M XXX $18.5M XXX XXX XXX
EV (current) $10.1M XXX $10.1M XXX XXX XXX
EV/Revenue 1.9x XXX 1.0x XXX XXX XXX
EV/EBITDA n/a XXX -2.0x XXX XXX XXX
EV/EBIT -2.1x XXX -1.4x XXX XXX XXX
EV/Gross Profit 1.9x XXX n/a XXX XXX XXX
P/E -2.4x XXX -3.2x XXX XXX XXX
EV/FCF n/a XXX -0.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Aelis Farma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Aelis Farma Margins & Growth Rates

Aelis Farma's last 12 month revenue growth is 53%

Aelis Farma's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.8M for the same period.

Aelis Farma's rule of 40 is -318% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Aelis Farma's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Aelis Farma and other 12K+ public comps

Aelis Farma Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 53% XXX 17% XXX XXX XXX
EBITDA Margin n/a XXX -51% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 -318% XXX 2% XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $0.4M XXX XXX XXX
Opex per Employee XXX XXX $0.8M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 179% XXX XXX XXX
Opex to Revenue XXX XXX 171% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms
Explore Valuation Multiples by Industry
Start Free Trial

Aelis Farma Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Aelis Farma M&A and Investment Activity

Aelis Farma acquired  XXX companies to date.

Last acquisition by Aelis Farma was  XXXXXXXX, XXXXX XXXXX XXXXXX . Aelis Farma acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Aelis Farma

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Aelis Farma

When was Aelis Farma founded? Aelis Farma was founded in 2013.
Where is Aelis Farma headquartered? Aelis Farma is headquartered in France.
How many employees does Aelis Farma have? As of today, Aelis Farma has 23 employees.
Who is the CEO of Aelis Farma? Aelis Farma's CEO is Mr. Pier Vincenzo Piazza.
Is Aelis Farma publicy listed? Yes, Aelis Farma is a public company listed on PAR.
What is the stock symbol of Aelis Farma? Aelis Farma trades under AELIS ticker.
When did Aelis Farma go public? Aelis Farma went public in 2022.
Who are competitors of Aelis Farma? Similar companies to Aelis Farma include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Aelis Farma? Aelis Farma's current market cap is $18.5M
What is the current revenue of Aelis Farma? Aelis Farma's last 12 months revenue is $5.2M.
What is the current revenue growth of Aelis Farma? Aelis Farma revenue growth (NTM/LTM) is 53%.
What is the current EV/Revenue multiple of Aelis Farma? Current revenue multiple of Aelis Farma is 1.9x.
Is Aelis Farma profitable? Yes, Aelis Farma is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.

Start Free Trial 🎦 Book a Call